Cranebio Co.,Ltd
New concept wearable feminine testers and infectious disease self-testing kits based on the DNA origami technology
New concept wearable feminine testers and infectious disease self-testing kits based on the DNA origami technology
Cranebio Co.,Ltd is a Health Care startup, founded in 2021 in Japan. The company aims to revolutionize the market with its innovative wearable feminine testers and infectious disease self-testing kits. Leveraging DNA origami technology, Cranebio is developing femtech products for early detection of female-specific diseases and everyday health management for women. Their infectious disease self-testing kits cover ailments such as COVID-19 and HPV, while also offering rapid water inspection kits. The latest milestone for Cranebio was a significant ¥250.00M Series A investment secured on 04 October 2023. This round of funding saw participation from esteemed venture capital firms including Nippon Venture Capital, Axil Capital, and Akigin Capital Partners. The company's vision and robust technology indicate potential for growth and disruption in the health tech industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | ¥250.00M | 3 |
|
04 Oct 2023 |
No recent news or press coverage available for Cranebio Co.,Ltd.
We care about your data, and we'd love to use cookies make your experience better.